Robert J Fountaine

6PUBLICATIONS
14CO-AUTHORS
Models of care and place of birthTraditional Chinese medicine and treatmentsPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 11, 2025
Patient-Reported Outcomes During the Acute Treatment of Migraine with Zavegepant Nasal Spray: Results from a 52-Week, Open-Label Study.

Richard B Lipton, Linda Mosher, Robert J Fountaine

|Nov 19, 2025
A phase 4, randomized, double-blind, placebo-controlled trial evaluating the efficacy and tolerability of rimegepant for the prevention of episodic migraine in adults with a history of inadequate response to traditional oral preventive medications.

Patricia Pozo-Rosich, José Antonio Gien López, Pawel Lisewski

|Nov 19, 2025
Rimegepant for acute treatment of migraine in triptan-unsuitable adults: A randomized, double-blind, placebo-controlled phase 4 trial.

Messoud Ashina, Peter McAllister, Charly Gaul

|Oct 09, 2025
Rimegepant for the acute treatment of migraine: A phase 3, multicenter, open-label, long-term safety and effectiveness study in adults from China.

Mingjie Zhang, Aihong Guo, Jin Wu

|Jun 18, 2025
A Pharmacokinetic Study of Zavegepant Nasal Spray in Healthy Adults Comparing Conventional Venous Blood Sampling With Patient-Centric Microsampling.

Mohamed H Shahin, Ogert Fisniku, Ding Ding

|Jun 10, 2025
Efficacy and safety of rimegepant 75 mg for acute treatment of migraine: a pooled analysis of four randomized, placebo-controlled trials.

Stewart J Tepper, Jelena M Pavlovic, Shengyuan Yu

Pageof 1

Frequent Collaborators

2 joint publications

Shengyuan Yu

1 joint publications

Patricia Pozo-Rosich

1 joint publications

José Antonio Gien López

1 joint publications

Stewart J Tepper